Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells

Abstract

Here we report the specific regulation of gadd45 expression in human melanoma cell lines following UVB radiation. This solar wavelength is likely to be involved in melanoma aetiology. We have previously shown that gadd45 expression is strongly enhanced in a p53-independent manner following UVB irradiation, unlike the other p53 target genes studied. Furthermore, gadd45 is specifically activated in melanocytes since its induction in response to UVB, is not observed in other skin cells such as keratinocytes or fibroblasts. To investigate this particular regulation of gadd45, we analysed the UVB-induced response of different gadd45 promoter regions. Thus, a minimal promoter region of 50 bp length, responsible for gadd45 activation in melanoma cell lines following UVB irradiation, was determined. In electrophoretic mobility shift assays (EMSAs), we showed that this region (−106/−56) of the gadd45 promoter which contains two identical octamers, binds the POU family gene products oct-1 and N-oct3. Given the specific expression pattern of N-oct3 in melanocyte, we invalidated the expression of this transcription factor in melanoma cells: such an abrogation of N-oct3 protein expression in melanoma cells impeded gadd45 UVB-response. Thus the response of melanocyte to UVB may use an original and previously undescribed pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Atillasoy ES, Seykora JT, Soballe PW, Elenitsas R, Nesbit M, Elder DE, Montone KT, Sauter E, Herlyn M . 1998 Am. J. Pathol. 152: 1179–1186

  • Bae I, Smith ML, Sheikh MS, Zhan Q, Scudiero DA, Friend SH, O'Connor PM, Fornace Jr AJ . 1996 Cancer Res. 56: 840–847

  • Bender K, Blattner C, Knebel A, Iordanov M, Herrlich P, Rahmsdorf HJ . 1997 J. Photochem. Photobiol. B 37: 1–17

  • Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y, Fornace Jr AJ . 1999 Mol. Cell. Biol. 19: 1673–1685

  • Carrier F, Smith ML, Bae I, Kilpatrick KE, Lansing TJ, Chen CY, Engelstein M, Friend SH, Henner WD, Gilmer TM, Kastan MB, Fornace Jr AJ . 1994 J. Biol. Chem. 269: 32672–32677

  • Chin PL, Momand J, Pfeifer GP . 1997 Oncogene 15: 87–99

  • Devary Y, Gottlieb RA, Lau LF, Karin M . 1991 Mol. Cell. Biol. 11: 2804–2811

  • Eller MS, Maeda T, Magnoni C, Atwal D, Gilchrest BA . 1997 Proc. Natl. Acad. Sci. USA 94: 12627–12632

  • Gilchrest BA, Eller MS, Geller AC, Yaar M . 1999 N. Engl. J. Med. 340: 1341–1348

  • Graunke DM, Fornace Jr AJ, Pieper RO . 1999 Nucleic Acids Res. 27: 3881–3890

  • Haapajarvi T, Pitkanen K, Laiho M . 1999 Cell Growth Differ. 10: 163–171

  • Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E, Cox LS . 1995 Oncogene 10: 2427–2433

  • Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace Jr AJ . 1993 J. Biol. Chem. 268: 24385–24393

  • Inamoto S, Segil N, Pan ZQ, Kimura M, Roeder RG . 1997 J. Biol. Chem. 272: 29852–29858

  • Jacubovich R, Cabrillat H, Gerlier D, Bailly M, Dore JF . 1985 Br. J. Cancer 51: 335–345

  • Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, Alomo I, Rajasekaran B, Zhan Q . 2001 Oncogene 20: 2683–2690

  • Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace Jr AJ, Zhan Q . 2000 Oncogene 19: 4050–4057

  • Kallassy M, Toftgard R, Ueda M, Nakazawa K, Vorechovsky I, Yamasaki H, Nakazawa H . 1997 Cancer Res. 57: 4731–4735

  • Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ . 1992 Cell 71: 587–597

  • Kearsey JM, Coates PJ, Prescott AR, Warbrick E, Hall PA . 1995 Oncogene 11: 1675–1683

  • Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo Jr I, Barrett SF, Hickson ID, Fornace Jr AJ . 1991 Mol. Cell Biol. 11: 1009–1016

  • Pedeux R, Al-Irani N, Marteau C, Pellicier F, Branche R, Ozturk M, Franchi J, Dore JF . 1998 J. Invest. Dermatol. 111: 472–477

  • Roberts SB, Segil N, Heintz N . 1991 Science 253: 1022–1026

  • Ronai Z, Rutberg S, Yang YM . 1994 Environ. Mol. Mutagen. 23: 157–163

  • Rosfjord E, Scholtz B, Lewis R, Rizzino A . 1995 Biochem. Biophys. Res. Commun. 212: 847–853

  • Schreiber E, Matthias P, Muller MM, Schaffner W . 1989 Nucleic Acids Res. 17: 6419

  • Schreiber E, Tobler A, Malipiero U, Schaffner W, Fontana A . 1993 Nucleic Acids Res. 21: 253–258

  • Setlow RB, Woodhead AD, Grist E . 1989 Proc. Natl. Acad. Sci. USA 86: 8922–8926

  • Smith AG, Brightwell G, Smit SE, Parsons PG, Sturm RA . 1998 Melanoma. Res. 8: 2–10

  • Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace Jr AJ . 1994 Science 266: 1376–1380

  • Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM, Fornace Jr AJ . 1996 Oncogene 13: 2255–2263

  • Sturm RA, Bisshop F, Takahashi H, Parsons PG . 1991 Cell Growth Differ. 2: 519–524

  • Sturm RA, Das G, Herr W . 1988 Genes Dev. 2: 1582–1599

  • Sturm RA, O'Sullivan BJ, Thomson JA, Jamshidi N, Pedley J, Parsons PG . 1994 Pigment Cell Res. 7: 235–240

  • Takahashi S, Saito S, Ohtani N, Sakai T . 2001 Cancer Res. 61: 1187–1195

  • Thomson JA, Murphy K, Baker E, Sutherland GR, Parsons PG, Sturm RA, Thomson F . 1995 Oncogene 11: 691–700

  • Thomson JA, Parsons PG, Sturm RA . 1993 Pigment Cell Res. 6: 13–22

  • Verrijzer CP, van Oosterhout JA, van der Vliet PC . 1992 Mol. Cell Biol. 12: 542–551

  • Vigano MA, Staudt LM . 1996 Nucleic Acids Res. 24: 2112–2118

  • Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, Bart RS . 2001 J. Am. Acad. Dermatol. 44: 837–846

  • Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ, Harris CC . 1999 Proc. Natl. Acad. Sci. USA 96: 3706–3711

  • Westerdahl J, Ingvar C, Masback A, Jonsson N, Olsson H . 2000 Br. J. Cancer 82: 1593–1599

  • Wolf P, Donawho CK, Kripke ML . 1994 J. Natl. Cancer Inst. 86: 99–105

  • Xiao G, Chicas A, Olivier M, Taya Y, Tyagi S, Kramer FR, Bargonetti J . 2000 Cancer Res. 60: 1711–1719

  • Yang Q, Manicone A, Coursen JD, Linke SP, Nagashima M, Forgues M, Wang XW . 2000 J. Biol. Chem. 275: 36892–36898

  • Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace Jr AJ . 1999 Oncogene 18: 2892–2900

  • Zhan Q, Bae I, Kastan MB, Fornace Jr AJ . 1994 Cancer Res. 54: 2755–2760

  • Zhan Q, Carrier F, Fornace Jr AJ . 1993 Mol. Cell. Biol. 13: 4242–4250

  • Zhan Q, Chen IT, Antinore MJ, Fornace Jr AJ . 1998 Mol. Cell. Biol. 18: 2768–2778

  • Zhao H, Jin S, Fan F, Fan W, Tong T, Zhan Q . 2000 Cancer Res. 60: 6276–6280

Download references

Acknowledgements

We thank J Franchi for providing the human normal primary keratinocytes (Parfums Christian Dior, France) and M Strubin, U Malipiero and W Schaffner (Zürich) for the gift of various plasmids. We thank Marie-Dominique Reynaud for editorial assistance and R Pedeux, M Kallassy, M Billaud and ML Vignais for helpful discussions. This work was supported by INSERM and by grants from the ‘Association pour la Recherche sur le Cancer’ (ARC 5649) and from the ‘Ligue contre le Cancer - Comité Départemental du Rhône’. K Lefort is a recipient of a fellowship from the ‘Ligue contre le Cancer - Comité Départemental de la Haute-Savoie’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-François Doré.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lefort, K., Rouault, JP., Tondereau, L. et al. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells. Oncogene 20, 7375–7385 (2001). https://doi.org/10.1038/sj.onc.1204923

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204923

Keywords

This article is cited by

Search

Quick links